632 related articles for article (PubMed ID: 17945546)
1. Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro.
Bonnelye E; Chabadel A; Saltel F; Jurdic P
Bone; 2008 Jan; 42(1):129-38. PubMed ID: 17945546
[TBL] [Abstract][Full Text] [Related]
2. Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation.
Marie PJ
Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S11-5. PubMed ID: 16735840
[TBL] [Abstract][Full Text] [Related]
3. Strontium ranelate: a physiological approach for optimizing bone formation and resorption.
Marie PJ
Bone; 2006 Feb; 38(2 Suppl 1):S10-4. PubMed ID: 16439191
[TBL] [Abstract][Full Text] [Related]
4. Strontium as therapy for osteoporosis.
Marie PJ
Curr Opin Pharmacol; 2005 Dec; 5(6):633-6. PubMed ID: 16183330
[TBL] [Abstract][Full Text] [Related]
5. [Strontium ranelate: a novel concept for the treatment of osteoporosis].
Dimai HP
Wien Klin Wochenschr; 2005 Nov; 117(21-22):728-38. PubMed ID: 16416353
[TBL] [Abstract][Full Text] [Related]
6. Induction of a program gene expression during osteoblast differentiation with strontium ranelate.
Zhu LL; Zaidi S; Peng Y; Zhou H; Moonga BS; Blesius A; Dupin-Roger I; Zaidi M; Sun L
Biochem Biophys Res Commun; 2007 Apr; 355(2):307-11. PubMed ID: 17300752
[TBL] [Abstract][Full Text] [Related]
7. Strontium ranelate in osteoporosis.
Reginster JY
Curr Pharm Des; 2002; 8(21):1907-16. PubMed ID: 12171530
[TBL] [Abstract][Full Text] [Related]
8. Strontium ranelate decreases receptor activator of nuclear factor-ΚB ligand-induced osteoclastic differentiation in vitro: involvement of the calcium-sensing receptor.
Caudrillier A; Hurtel-Lemaire AS; Wattel A; Cournarie F; Godin C; Petit L; Petit JP; Terwilliger E; Kamel S; Brown EM; Mentaverri R; Brazier M
Mol Pharmacol; 2010 Oct; 78(4):569-76. PubMed ID: 20584969
[TBL] [Abstract][Full Text] [Related]
9. Strontium ranelate: an increased bone quality leading to vertebral antifracture efficacy at all stages.
Ortolani S; Vai S
Bone; 2006 Feb; 38(2 Suppl 1):19-22. PubMed ID: 16455319
[TBL] [Abstract][Full Text] [Related]
10. [Strontium Ranelate as a new therapeutic agent for osteoporosis].
Imanishi Y; Nishizawa Y
Clin Calcium; 2005 Jan; 15(1):25-8. PubMed ID: 15632469
[TBL] [Abstract][Full Text] [Related]
11. The intact strontium ranelate complex stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-κB activation.
Yamaguchi M; Weitzmann MN
Mol Cell Biochem; 2012 Jan; 359(1-2):399-407. PubMed ID: 21874315
[TBL] [Abstract][Full Text] [Related]
12. The Calcium-sensing Receptor (CaR) is involved in strontium ranelate-induced osteoblast differentiation and mineralization.
Takaoka S; Yamaguchi T; Yano S; Yamauchi M; Sugimoto T
Horm Metab Res; 2010 Aug; 42(9):627-31. PubMed ID: 20560105
[TBL] [Abstract][Full Text] [Related]
13. A new treatment for post-menopausal osteoporosis: strontium ranelate.
Rizzoli R
J Endocrinol Invest; 2005; 28(8 Suppl):50-7. PubMed ID: 16323829
[TBL] [Abstract][Full Text] [Related]
14. [Strontium ranelate's (Osseor) dual mode of action: increasing bone mass and decreasing bone resorption].
Kaliterna DM
Reumatizam; 2008; 55(2):73-4. PubMed ID: 19024281
[TBL] [Abstract][Full Text] [Related]
15. Strontium ranelate: a new paradigm in the treatment of osteoporosis.
Reginster JY; Deroisy R; Jupsin I
Drugs Today (Barc); 2003 Feb; 39(2):89-101. PubMed ID: 12698204
[TBL] [Abstract][Full Text] [Related]
16. Strontium ranelate promotes osteoblastic differentiation and mineralization of murine bone marrow stromal cells: involvement of prostaglandins.
Choudhary S; Halbout P; Alander C; Raisz L; Pilbeam C
J Bone Miner Res; 2007 Jul; 22(7):1002-10. PubMed ID: 17371157
[TBL] [Abstract][Full Text] [Related]
17. Protelos: nonvertebral and hip antifracture efficacy in postmenopausal osteoporosis.
Adami S
Bone; 2006 Feb; 38(2 Suppl 1):23-7. PubMed ID: 16434247
[TBL] [Abstract][Full Text] [Related]
18. Strontium ranelate: a novel mode of action optimizing bone formation and resorption.
Marie PJ
Osteoporos Int; 2005 Jan; 16 Suppl 1():S7-10. PubMed ID: 15578159
[TBL] [Abstract][Full Text] [Related]
19. Strontium ranelate: a new treatment for postmenopausal osteoporosis with a dual mode of action.
Reginster JY; Sarlet N; Lejeune E; Leonori L
Curr Osteoporos Rep; 2005 Mar; 3(1):30-4. PubMed ID: 16036099
[TBL] [Abstract][Full Text] [Related]
20. Improvement in bone strength parameters. The role of strontium ranelate.
Tournis S
J Musculoskelet Neuronal Interact; 2007; 7(3):266-7. PubMed ID: 17947810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
